Emergent BioSolutions
EBS
#6973
Rank
ยฃ0.28 B
Marketcap
ยฃ5.33
Share price
1.30%
Change (1 day)
77.84%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.85 B

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are ยฃ0.85 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.92 B-37.32%
2022-12-31ยฃ1.47 B47.8%
2021-12-31ยฃ0.99 B-5.45%
2020-12-31ยฃ1.05 B12.7%
2019-12-31ยฃ0.93 B-2.25%
2018-12-31ยฃ0.95 B717.39%
2017-12-31ยฃ0.11 B-61.44%
2016-12-31ยฃ0.30 B19.09%
2015-12-31ยฃ0.25 B2.75%
2014-12-31ยฃ0.24 B197.5%
2013-12-31ยฃ83.23 M10.23%
2012-12-31ยฃ75.5 M-9.82%
2011-12-31ยฃ83.72 M1.62%
2010-12-31ยฃ82.39 M31.11%
2009-12-31ยฃ62.84 M-0.9%
2008-12-31ยฃ63.41 M23.72%
2007-12-31ยฃ51.25 M0.62%
2006-12-31ยฃ50.94 M116.4%
2005-12-31ยฃ23.54 M-2.07%
2004-12-31ยฃ24.03 M
2002-12-31ยฃ11.62 M-70.8%
2001-12-31ยฃ39.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ52.56 B 6,019.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ19.12 M-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.70 B 4,872.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ24.32 M-97.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ97.69 B 11,274.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.49 B 2,985.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ4.87 M-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA